ProPhase Labs Inc. has received a notification that its common stock, listed on the Nasdaq Capital Market under the symbol PRPH, will be suspended from trading at the opening of business on January 5, 2026. The suspension was requested by Nasdaq after the company failed to regain compliance with the minimum bid price requirement under Listing Rule 5550(a)(2).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-000175), on January 02, 2026, and is solely responsible for the information contained therein.
Comments